این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
International Journal of Pediatrics، جلد ۴، شماره ۱۲، صفحات ۴۰۳۳-۴۰۴۱
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Treatment Costs for Pediatrics Acute Lymphoblastic Leukemia; Comparing Clinical Expenditures in Developed and Developing Countries: a Review Article
چکیده انگلیسی مقاله Background Pediatric acute lymphoblastic leukemia (ALL) is the most common, yet curable childhood malignancy within the pediatric cancers; but in most developed and developing countries cost of cancer treatment in children with ALL is high. So, we specified the range of expenses for the treatment of pediatric cancer and compared the results in developed and developing countries.Materials and MethodsTo evaluate treatment costs in childhood ALL, a review was taken place through published papers during the years 2000 to 2015. We searched multiple well known databases such as Medline, Scopus, ISI Web of Science and Google Scholar on January 2015 with "cost effectiveness", "cost utility", "cost minimization", "cost analysis", "economic evaluation", "childhood", "acute lymphoblastic leukemia", and "ALL" as our keywords.ResultsRegarding the reviewed evidence the essential result was that the total costs for treatment of pediatrics ALL in developing countries such as Asian countries were considerably lower than the costs reported from high income countries in Europe and North America. So different protocols were performed to treat ALL and this matter was significant due to the different durations of hospitalization.ConclusionAccording to the results, the total costs for treatment of pediatrics ALL in developing countries were considerably lower than the costs reported from high income countries.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله هادی حیاتی | hadi hayati
department of pharmacoeconomics and pharmaceutical administration, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

عباس کبریایی زاده | abbas kebriaeezadeh
department of pharmacoeconomics and pharmaceutical administration, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

محمد علی احسانی | mohammad ali ehsani
department of pediatric hematology and oncology, bahrami hospital, tehran university of medical sciences, tehran, ir iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

شکوفه نیک فر | shekoufeh nikfar
department of pharmacoeconomics and pharmaceutical administration, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

علی اکبری ساری | ali akbari sari
department of health management and economics, tehran university of medical sciences, tehran, ir iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

مهدی طرسکی | mehdi troski
department of pharmacoeconomics and pharmaceutical administration, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

bereket ملا tigabu | bereket molla tigabu
international campus, department of pharmacoeconomics and pharmaceutical management haramaya university school of pharmacy.
نشانی اینترنتی http://ijp.mums.ac.ir/article_7791.html
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/317/article-317-279414.pdf
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات